Metz-Gercek Sigrid, Mittermayer Helmut
Department of Hygiene, Microbiology and Tropical Medicine, National Reference Center for Nosocomial Infections and Antibiotic Resistance, Elisabethinen Hospital Linz, Austria.
Wien Klin Wochenschr. 2008;120(9-10):264-7. doi: 10.1007/s00508-008-0967-8.
Development of resistance obstructs the successful use of antimicrobial drugs, since shortly after each and every introduction of a new antibiotic resistant pathogens have emerged. The hope of being able to reverse or at least slow down the occurrence of antibiotic resistance has led to a number of actions and initiatives. The project "ABS International - Implementing antibiotic strategies for appropriate use of antibiotics in hospitals in member states of the European Union", together with the European Antimicrobial Resistance Surveillance System (EARSS) and the European Surveillance on Antimicrobial Consumption (ESAC), covers a large proportion of possible actions against antibiotic resistance. The data generated by EARSS and ESAC are an essential prerequisite for targeted interventions to cope with the problem of antibiotic resistance. The project ABS International constitutes an impressive initiative to optimize the situation in hospitals in nine European member states.
耐药性的产生阻碍了抗菌药物的成功使用,因为每一种新抗生素投入使用后不久,耐药病原体就会出现。能够逆转或至少减缓抗生素耐药性出现的希望引发了一系列行动和倡议。“ABS国际——在欧盟成员国医院实施抗生素合理使用策略”项目,连同欧洲抗菌药物耐药性监测系统(EARSS)和欧洲抗菌药物消费监测(ESAC),涵盖了针对抗生素耐药性的大部分可能行动。EARSS和ESAC生成的数据是应对抗生素耐药性问题进行有针对性干预的重要前提。ABS国际项目是一项令人瞩目的倡议,旨在优化九个欧洲成员国医院的情况。